All European countries are only administering mRNA vaccines.

European countries administer a number of different vaccines, not just mRNA vaccines.

European countries administer a number of different vaccines, not just mRNA vaccines.COVID-19 vaccines are being manufactured and marketed in bulk, as the global vaccination drive picks up pace. This has led to misinformation concerning vaccines and their efficacy. One example of this is the false claim that European countries only administer mRNA vaccines.

As The Global Alliance for Vaccines and Immunisation explains, four vaccines have been developed to combat COVID-19; whole virus vaccines, protein subunit vaccines, viral victor vaccines, and nucleic acid (RNA/mRNA and DNA) vaccines, where some try to smuggle the antigen into the body, and others use the body's cells to make the viral antigen.

European Centre for Disease Prevention and Control (ECDC) lists the vaccines approved and distributed in European Union/European Economic Area (EU/EEA) countries and by what percentage. Comirnaty (BNT162b2), developed by BioNTech/Pfizer(67.3 percent), followed by Vaxzevria (AZD1222), previously called AstraZeneca (19.5 percent), Moderna (9.6 percent), and Janssen (3.3 percent). Meanwhile, EU countries like Hungary are also administering Beijing CNBG and Sputnik V COVID-19 vaccines, where seventeen countries recommend specific COVID-19 vaccine products for specific population groups.

EU/EEA countries administer both mRNA and vector-based COVID-19 vaccines against the disease. Comirnaty and Moderna are mRNA-based vaccines, while Vaxzevria, Janssen, and Sputnik V are viral vector-based vaccines. Beijing CNBG/Sinopharm is Vero cell-based vaccine.

As of June 22, 330,719,624 doses of vaccine have been administered in EU countries.